Skip to main content

Advertisement

Log in

Gaps in Adhering to Pap Testing Recommendations and Related Barriers in a Sample of Young Adults in the US

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

Abstract

Given ongoing gaps in adherence to Pap testing recommendations, this study examined: 1) adherence to Pap test screening recommendations; and 2) barriers to Pap test screening among those who were nonadherent, using constructs from the Andersen model. We analyzed Spring 2022 survey data among 541 US young adults who reported having a cervix (n = 541; mean age = 27.73, 42.1% heterosexual, 57.9% sexual minority, 86.0% woman, 3.7% transgender man, 68.2% White, 31.8% racial/ethnic minority). Multivariable logistic regression examined sociodemographic correlates of nonadherence to Pap testing recommendations (i.e., no Pap testing in the past 3 years). Among those who were nonadherent, barriers to Pap testing were assessed. 68.6% (n = 371) were defined as adherent and 31.4% (n = 170) nonadherent. Multivariable regression findings indicated significant differences by race/ethnicity such that Asians (vs. Whites) were more likely to be nonadherent (OR = 2.41, CI = 1.11, 3.70, p = .021); no other differences in relation to race/ethnicity or sexual/gender identity were found. The most commonly reported barriers were: “I have not gotten around to it” (42.9%), “getting a Pap test is just not a priority for me” (30.6%), “fear/worry” (28.2%), “dislike/don’t like having procedures done” (27.1%), “my healthcare provider has never mentioned it” (21.2%), “haven’t had sex so I don’t consider myself at high risk” (20.6%), and “COVID-19 pandemic prevented me” (15.3%). Pap testing is underutilized among young adults in the US, particularly Asians. Multilevel interventions must address barriers within the healthcare system (e.g., provider recommendation), external environment (e.g., societal factors), and individual realm (e.g., perceptions).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

Data not publicly available (available upon request).

References

  1. Domogauer J et al (2022) Disparities in cancer screenings for sexual and gender minorities. Curr Probl Cancer 46(5):100858

    Article  PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention (2022) Cancers Caused by HPV. Available from: https://www.cdc.gov/hpv/parents/cancer.html#:~:text=More%20than%209%20of%20every,diagnosed%20with%20a%20cervical%20precancer. Accessed 9 July 2023

  3. Brisson M, Drolet M (2019) Global elimination of cervical cancer as a public health problem. Lancet Oncol 20(3):319–321

    Article  PubMed  Google Scholar 

  4. American Cancer Society (2023) Cancer facts & figures 2023. Available from: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html. Accessed 9 July 2023

  5. Haviland KS et al (2020) Barriers and facilitators to cancer screening among LGBTQ individuals with cancer. Oncol Nurs Forum 47(1):44–55

    Article  PubMed  PubMed Central  Google Scholar 

  6. Datta GD et al (2022) Racial/ethnic inequalities in cervical cancer screening in the United States: an outcome reclassification to better inform interventions and benchmarks. Prev Med 159:107055

    Article  PubMed  Google Scholar 

  7. Yoo W et al (2017) Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States. PLoS ONE 12(2):e0172548

    Article  PubMed  PubMed Central  Google Scholar 

  8. Musselwhite LW et al (2016) Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytol 60(6):518–526

    Article  PubMed  Google Scholar 

  9. Centers for Disease Control and Prevention (2022) Leading Cancer Cases and Deaths, All Races and Ethnicities, Male and Female, 2019. Available from: https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/AtAGlance/. Accessed 9 July 2023

  10. U.S. Preventive Sevices Task Force (2018) Cervical Cancer: Screening. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening#bootstrap-panel--5. Accessed 9 July 2023

  11. Centers for Disease Control and Prevention (2022) What Should I Know About Screening? Available from: https://www.cdc.gov/cancer/cervical/basic_info/screening.htm. Accessed 9 July 2023

  12. Ahmed NU, Rojas P, Degarege A (2020) Knowledge of cervical cancer and adherence to pap smear screening test among female university students in a Multiethnic Institution, USA. J Natl Med Assoc 112(3):300–307

    PubMed  Google Scholar 

  13. Fuzzell LN et al (2021) Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups. Prev Med 144:106400

    Article  PubMed  Google Scholar 

  14. White A et al (2017) Cancer screening test use - United States, 2015. MMWR Morb Mortal Wkly Rep 66(8):201–206

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lombardo J et al (2022) Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity. Cancer Causes Control 33(4):559–582

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kaiser Family Foundation (2022) Racial Disparities in Cancer Outcomes, Screening, and Treatment.; Available from: https://www.kff.org/racial-equity-and-health-policy/issue-brief/racial-disparities-in-cancer-outcomes-screening-and-treatment/. Accessed 9 July 2023

  17. Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1–10

    Article  CAS  PubMed  Google Scholar 

  18. Phillips KA et al (1998) Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res 33(3 Pt 1):571–596

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Seo JY, Bae SH, Dickerson SS (2016) Korean Immigrant Women’s Health Care Utilization in the United States: a systematic review of literature. Asia Pac J Public Health 28(2):107–133

    Article  PubMed  Google Scholar 

  20. Seo JY et al (2019) Factors influencing health service utilization among asian immigrant nail salon workers in the greater New York City area. J Community Health 44(1):1–11

    Article  PubMed  PubMed Central  Google Scholar 

  21. Berg CJ et al (2021) Young adult e-cigarette use and retail exposure in 6 US metropolitan areas. Tob Regul Sci 7(1):59–75

    Article  PubMed  PubMed Central  Google Scholar 

  22. Public Health Law Center (2020) Available from: https://www.publichealthlawcenter.org/topics/commercial-tobacco-control/commercial-tobacco-and-marijuana. Accessed 9 July 2023

  23. Guvenc G, Akyuz A, Açikel CH (2011) Health belief model scale for cervical cancer and pap smear test: psychometric testing. J Adv Nurs 67(2):428–437

    Article  PubMed  Google Scholar 

  24. Ogunwale AN et al (2016) Non-utilization of the pap test among women with frequent health system contact. J Immigr Minor Health 18(6):1404–1412

    Article  PubMed  Google Scholar 

  25. McDaniel CC et al (2021) Persistent racial disparities in cervical cancer screening with Pap test. Prev Med Rep 24:101652

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chawla N et al (2015) Asian American women in California: a pooled analysis of predictors for breast and cervical cancer screening. Am J Public Health 105(2):e98–e109

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ma GX et al (2015) Increasing cervical cancer screening among Vietnamese Americans: a community-based intervention trial. J Health Care Poor Underserved 26(2 Suppl):36–52

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fang CY et al (2019) Community-based cervical cancer education: changes in knowledge and beliefs among Vietnamese American women. J Community Health 44(3):525–533

    Article  PubMed  PubMed Central  Google Scholar 

  29. Charkhchi P, Schabath MB, Carlos RC (2019) Modifiers of cancer screening prevention among sexual and gender minorities in the behavioral risk factor surveillance system. J Am Coll Radiol 16(4 Pt B):607–620

    Article  PubMed  Google Scholar 

  30. Kiran T et al (2019) Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician 65(1):e30–e37

    PubMed  PubMed Central  Google Scholar 

  31. Seay J et al (2017) Understanding transgender men’s experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health 4(4):304–309

    Article  PubMed  Google Scholar 

  32. Suk R et al (2022) Assessment of US preventive services task force guideline-concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019. JAMA Netw Open 5(1):e2143582

    Article  PubMed  PubMed Central  Google Scholar 

  33. Seo JY, Li J, Li K (2018) Cervical cancer screening experiences among Chinese American immigrant women in the United States. J Obstet Gynecol Neonatal Nurs 47(1):52–63

    Article  PubMed  Google Scholar 

  34. Wyatt LC et al (2023) A culturally adapted breast and cervical cancer screening intervention among Muslim women in New York city: results from the MARHABA Trial. J Cancer Educ 38(2):682–690

    Article  PubMed  Google Scholar 

  35. Lee HY et al (2019) Development of a mobile health intervention to promote papanicolaou tests and human papillomavirus vaccination in an underserved immigrant population: a culturally targeted and individually tailored text messaging approach. JMIR Mhealth Uhealth 7(6):e13256

    Article  PubMed  PubMed Central  Google Scholar 

  36. Han H-R et al (2023) Community-based health literacy focused intervention for cervical cancer control among Black women living with human immunodeficiency virus: a randomized pilot trial. Health Expect 26(1):172–182

    Article  PubMed  Google Scholar 

  37. Ruco A et al (2021) Social media and mHealth technology for cancer screening: systematic review and meta-analysis. J Med Internet Res 23(7):e26759

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lofters A, Vahabi M, Glazier RH (2015) The validity of self-reported cancer screening history and the role of social disadvantage in Ontario, Canada. BMC Public Health 15:28

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was approved by the Emory University Institutional Review Board (IRB00097895).

Funding

This work was supported by the US National Cancer Institute (R01CA215155, PI: Berg; R01CA215155-S1, PI: Le). Dr. Romm is supported by the American Cancer Society (134128-IRG-19–142; PI: Romm), Oklahoma Tobacco Settlement Endowment Trust (TSET) contract #R22-03, the National Cancer Institute grant awarded to the Stephenson Cancer Center (P30CA225520), and the National Institute on Drug Abuse (R25DA054015, MPIs: Obasi, Reitzel). Dr. Berg is also supported by other US National Institutes of Health funding, including the National Cancer Institute (R01CA239178, MPIs: Berg, Levine; R01CA278229, MPIs: Berg, Kegler; R01CA275066, MPIs: Yang, Berg; R21CA261884, MPIs: Berg, Arem), the Fogarty International Center (R01TW010664, MPIs: Berg, Kegler; D43TW012456, MPIs: Berg, Paichadze, Petrosyan), the National Institute of Environmental Health Sciences/Fogarty (D43ES030927, MPIs: Berg, Caudle, Sturua), and the National Institute on Drug Abuse (R01DA054751, MPIs: Berg, Cavazos-Rehg).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla J. Berg.

Ethics declarations

Conflicts of Interests

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sapra, T., Romm, K.F., Le, D. et al. Gaps in Adhering to Pap Testing Recommendations and Related Barriers in a Sample of Young Adults in the US. J Canc Educ 38, 1845–1852 (2023). https://doi.org/10.1007/s13187-023-02340-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-023-02340-6

Keywords

Navigation